FDA

Week in Review

Week in Review

Legislators seek answers on meningitis outbreak, business groups sue SEC over Dodd-Frank disclosure rule, and more.

Week in Review

Week in Review

White House group requests speedier drug approval, report details advantages of carbon tax, and more.

Report Highlights Difficulties with Regulating Federal Grants

Report Highlights Difficulties with Regulating Federal Grants

GAO identifies oversight challenges in administering federal grants to state and local governments.

FDA Finds Arsenic in Many Rice Products

FDA Finds Arsenic in Many Rice Products

Federal food safety agency says cutting rice consumption would be premature.

PPR Announces Fall 2012 Risk Regulation Series

PPR Announces Fall 2012 Risk Regulation Series

Three seminars will offer critical insights into regulation’s impact on business and society.

Proposition 37: Science, Law, and Consumer Protection

Proposition 37: Science, Law, and Consumer Protection

Californians will vote on whether to require the labeling of foods containing genetically modified products.

The Politics of Precaution

The Politics of Precaution

Explaining the shift in US and European approaches to risk regulation.

Patents, Patients, and Profits: Winners and Losers in Drug Patent Challenges

Patents, Patients, and Profits: Winners and Losers in Drug Patent Challenges

Challenges to branded drugs from generic firms have benefits and costs.

Member of Congress Documents “Loophole” for Medical Device Approval

Member of Congress Documents “Loophole” for Medical Device Approval

Advocacy groups join Rep. Markey in calling for reform of FDA review process.

FDA Rejects Petition to Ban BPA

FDA Rejects Petition to Ban BPA

Agency will continue to monitor the results of toxicity studies.

WTO Creates Roadblock to Administration’s Anti-Smoking Initiative

WTO Creates Roadblock to Administration’s Anti-Smoking Initiative

U.S. prohibition of flavored cigarettes violates international trade agreement.

Court Misapplies First Amendment to Strike Down FDA Cigarette Warning Labels

Court Misapplies First Amendment to Strike Down FDA Cigarette Warning Labels

A district court judge invents strict scrutiny requirement for commercial speech.